EM2309E "Progress in Polycystic Kidney Disease: Enhanced Assessment & Emerging Therapies" (IM GR-091523)

Purpose and Overview

Autosomal dominant polycystic kidney disease is the most common monogenic disorder in the United States. Fifty percent of individuals with ADPKD develop kidney failure. The purpose of this lecture is to educate general internists and subspecialists on the recent progress in the clinical management and therapeutic development of ADPKD.

Target Audience

UT Southwestern faculty, fellows, residents and medical students, community physicians, nurse clinicians, physician assistants and nurses.

Learning Objectives

At the conclusion of this activity, the participant should be able to:

  • Understand how to diagnose ADPKD.
  • Understand how to measure total kidney volume and determine Mayo imaging classification.
  • Appreciate the limitations of tolvaptan for the treatment of ADPKD.
Course summary
Available credit: 
  • 1.00 AMA
Course opens: 
Course expires: 

Photo: First Last, M.D.Ronak Lakhia, M.D.
Assistant Professor of Internal Medicine
Division of Nephrology

Available Credit

  • 1.00 AMA


Please login or create an account to take this course.

Required Hardware/software

Activities should be run with recent versions of common browsers, including Internet Explorer, Firefox and Google Chrome